XML 22 R5.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Seed Series Redeemable Convertible Preferred Stock
Series B Redeemable Convertible Preferred Stock
Series C Redeemable Convertible Preferred Stock
Common Equity
Additional Paid in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   81,790,144 0        
Beginning balance at Dec. 31, 2022   $ 81,525 $ 0        
Redeemable Convertible Preferred Stock              
Issuance of Series B redeemable convertible preferred stock, net of offering cost, expenses and discount (in shares)     37,073,162        
Issuance of Series B redeemable convertible preferred stock, net of offering cost, expenses and discount     $ 37,185        
Ending balance (in shares) at Mar. 31, 2023   81,790,144 37,073,162        
Ending balance at Mar. 31, 2023   $ 81,525 $ 37,185        
Beginning balance (in shares) at Dec. 31, 2022         504,544    
Beginning balance at Dec. 31, 2022 $ (98,803)       $ 2 $ 2,231 $ (101,036)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options (in shares)         10,428    
Issuance of common stock upon exercise of stock options 43         43  
Stock-based compensation 264         264  
Net loss (7,412)           (7,412)
Ending balance (in shares) at Mar. 31, 2023         514,972    
Ending balance at Mar. 31, 2023 (105,908)       $ 2 2,538 (108,448)
Beginning balance (in shares) at Dec. 31, 2022   81,790,144 0        
Beginning balance at Dec. 31, 2022   $ 81,525 $ 0        
Ending balance (in shares) at Sep. 30, 2023   81,790,144 76,097,548        
Ending balance at Sep. 30, 2023   $ 81,525 $ 85,003        
Beginning balance (in shares) at Dec. 31, 2022         504,544    
Beginning balance at Dec. 31, 2022 (98,803)       $ 2 2,231 (101,036)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (39,545)            
Ending balance (in shares) at Sep. 30, 2023         579,975    
Ending balance at Sep. 30, 2023 (137,111)       $ 2 3,468 (140,581)
Beginning balance (in shares) at Dec. 31, 2022   81,790,144 0        
Beginning balance at Dec. 31, 2022   $ 81,525 $ 0        
Ending balance (in shares) at Dec. 31, 2023   81,790,144 105,595,101 119,599,872      
Ending balance at Dec. 31, 2023 367,277 $ 81,525 $ 121,148 $ 164,604      
Beginning balance (in shares) at Dec. 31, 2022         504,544    
Beginning balance at Dec. 31, 2022 $ (98,803)       $ 2 2,231 (101,036)
Ending balance (in shares) at Dec. 31, 2023 640,386       640,386    
Ending balance at Dec. 31, 2023 $ (148,769)       $ 2 4,250 (153,021)
Beginning balance (in shares) at Mar. 31, 2023   81,790,144 37,073,162        
Beginning balance at Mar. 31, 2023   $ 81,525 $ 37,185        
Ending balance (in shares) at Jun. 30, 2023   81,790,144 37,073,162        
Ending balance at Jun. 30, 2023   $ 81,525 $ 37,185        
Beginning balance (in shares) at Mar. 31, 2023         514,972    
Beginning balance at Mar. 31, 2023 (105,908)       $ 2 2,538 (108,448)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options (in shares)         6,739    
Issuance of common stock upon exercise of stock options 27         27  
Vesting of restricted common stock (in shares)         54,035    
Stock-based compensation 352         352  
Net loss (9,288)           (9,288)
Ending balance (in shares) at Jun. 30, 2023         575,746    
Ending balance at Jun. 30, 2023 (114,817)       $ 2 2,917 (117,736)
Redeemable Convertible Preferred Stock              
Issuance of Series B redeemable convertible preferred stock, net of offering cost, expenses and discount (in shares)     39,024,386        
Issuance of Series B redeemable convertible preferred stock, net of offering cost, expenses and discount     $ 39,817        
Settlement of Series B preferred stock tranche rights liability, upon issuance of milestone shares     $ 8,001        
Ending balance (in shares) at Sep. 30, 2023   81,790,144 76,097,548        
Ending balance at Sep. 30, 2023   $ 81,525 $ 85,003        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options (in shares)         4,229    
Issuance of common stock upon exercise of stock options 32         32  
Stock-based compensation 519         519  
Net loss (22,845)           (22,845)
Ending balance (in shares) at Sep. 30, 2023         579,975    
Ending balance at Sep. 30, 2023 (137,111)       $ 2 3,468 (140,581)
Beginning balance (in shares) at Dec. 31, 2023   81,790,144 105,595,101 119,599,872      
Beginning balance at Dec. 31, 2023 $ 367,277 $ 81,525 $ 121,148 $ 164,604      
Ending balance (in shares) at Mar. 31, 2024   81,790,144 105,595,101 119,599,872      
Ending balance at Mar. 31, 2024   $ 81,525 $ 121,148 $ 164,604      
Beginning balance (in shares) at Dec. 31, 2023 640,386       640,386    
Beginning balance at Dec. 31, 2023 $ (148,769)       $ 2 4,250 (153,021)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options 50         50  
Stock-based compensation 1,147         1,147  
Net loss (12,508)           (12,508)
Ending balance (in shares) at Mar. 31, 2024         640,386    
Ending balance at Mar. 31, 2024 (160,080)       $ 2 5,447 (165,529)
Beginning balance (in shares) at Dec. 31, 2023   81,790,144 105,595,101 119,599,872      
Beginning balance at Dec. 31, 2023 367,277 $ 81,525 $ 121,148 $ 164,604      
Ending balance (in shares) at Sep. 30, 2024   0 0 0      
Ending balance at Sep. 30, 2024 $ 0 $ 0 $ 0 $ 0      
Beginning balance (in shares) at Dec. 31, 2023 640,386       640,386    
Beginning balance at Dec. 31, 2023 $ (148,769)       $ 2 4,250 (153,021)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options (in shares) 393,216            
Net loss $ (47,038)            
Ending balance (in shares) at Sep. 30, 2024 54,409,708       54,409,708    
Ending balance at Sep. 30, 2024 $ 509,555       $ 7 709,607 (200,059)
Beginning balance (in shares) at Mar. 31, 2024   81,790,144 105,595,101 119,599,872      
Beginning balance at Mar. 31, 2024   $ 81,525 $ 121,148 $ 164,604      
Ending balance (in shares) at Jun. 30, 2024   81,790,144 105,595,101 119,599,872      
Ending balance at Jun. 30, 2024   $ 81,525 $ 121,148 $ 164,604      
Beginning balance (in shares) at Mar. 31, 2024         640,386    
Beginning balance at Mar. 31, 2024 (160,080)       $ 2 5,447 (165,529)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options (in shares)         349,962    
Issuance of common stock upon exercise of stock options 1,315         1,315  
Vesting of restricted common stock (in shares)         33,193    
Stock-based compensation 1,038         1,038  
Net loss (17,049)           (17,049)
Ending balance (in shares) at Jun. 30, 2024         1,023,541    
Ending balance at Jun. 30, 2024 (174,776)       $ 2 7,800 (182,578)
Redeemable Convertible Preferred Stock              
Conversion of convertible preferred stock into common stock upon initial public offering (in shares)   (81,790,144) (105,595,101) (119,599,872)      
Conversion of convertible preferred stock into common stock upon initial public offering   $ (81,525) $ (121,148) $ (164,604)      
Ending balance (in shares) at Sep. 30, 2024   0 0 0      
Ending balance at Sep. 30, 2024 0 $ 0 $ 0 $ 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock, net of offering cost, expenses and discount (in shares)         20,125,000    
Issuance of common stock, net of offering cost, expenses and discount 332,429       $ 2 332,427  
Conversion of convertible preferred stock into common stock upon initial public offering (in shares)         33,210,876    
Conversion of convertible preferred stock into common stock upon initial public offering 367,153       $ 3 367,150  
Issuance of common stock upon exercise of stock options (in shares)         43,232    
Issuance of common stock upon exercise of stock options 199         199  
Vesting of restricted common stock (in shares)         7,059    
Stock-based compensation 2,031         2,031  
Net loss $ (17,481)           (17,481)
Ending balance (in shares) at Sep. 30, 2024 54,409,708       54,409,708    
Ending balance at Sep. 30, 2024 $ 509,555       $ 7 $ 709,607 $ (200,059)